R

REPLIMUNE LIMITED

9 employees

Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2015

Funding rounds raised

Total raised

$200M

from 12 investors over 12 rounds

R

REPLIMUNE LIMITED raised $200M on October 7, 2022

Investors: Hercules Capital, Inc.

R

REPLIMUNE LIMITED raised $55M on September 8, 2017

Investors: Omega Funds, Leerink Partners LLC, Research Division, Atlas Venture, Redmile Group, Foresite Capital and Forbion

R

REPLIMUNE LIMITED raised $30M on September 24, 2015

Investors: Omega Funds, Atlas Venture and Forbion

R

REPLIMUNE LIMITED raised $2M on May 8, 2015

Investors: Omega Funds and Forbion

FAQ